Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cost considerations of the new fixed combination for glaucoma medical therapy

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: CHEN, Hsien-Li (Chang Gung Memorial Hospital, Taipei, China Taiwan)
  • Co-author(s): Deng, Shin-Tarng (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
    Hsieh, Ming-Chieh (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
    Mau, Jan-Yen* (Chang Gung Memorial Hospital, TAIPEI, China Taiwan)
  • Abstract:

    Aims: To determine the daily cost of the CosoptÂ[RSYMBOL] (Dorzolamide/Timolol), CombiganÂ[RSYMBOL] (brimonidine tartrate/timolol), and XalacomÂ[RSYMBOL] (latanoprost /timolol) for medical therapy of glaucoma.

    Methods: The studied drugs were: CosoptÂ[RSYMBOL] (5.0 ml/ bottle) and CombiganÂ[RSYMBOL] (5.0 ml/ bottle), and XalacomÂ[RSYMBOL]..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses